Are IVIG for chronic unremitting urticaria effective?

被引：33
作者：
Asero, R [1 ]
机构：
[1] Osped Caduti Bollatesi, Abmulatorio Allergol, I-20021 Bollate, MI, Italy
来源：
ALLERGY | 2000年 / 55卷 / 11期
关键词：
autoimmunity; intravenous immunoglobulins; urticaria;
D O I：
10.1034/j.1398-9995.2000.00829.x
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1099 / 1101
页数：3
相关论文
共 10 条
  • [1] MODULATION OF AUTOIMMUNITY BY INTRAVENOUS IMMUNE GLOBULIN THROUGH INTERACTION WITH THE FUNCTION OF THE IMMUNE IDIOTYPIC NETWORK
    DIETRICH, G
    KAVERI, SV
    KAZATCHKINE, MD
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 62 (01): : S73 - S81
  • [2] Serum IgG autoantibodies directed against the a chain of Fc epsilon RI: A selective marker and pathogenetic factor for a distinct subset of chronic UrtiCaria patients?
    Fiebiger, E
    Maurer, D
    Holub, H
    Reininger, B
    Hartmann, G
    Woisetschlager, M
    Kinet, JP
    Stingl, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) : 2606 - 2612
  • [3] DETECTION OF CIRCULATING HISTAMINE RELEASING AUTOANTIBODIES WITH FUNCTIONAL-PROPERTIES OF ANTI-IGE IN CHRONIC URTICARIA
    GRATTAN, CEH
    FRANCIS, DM
    HIDE, M
    GREAVES, MW
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1991, 21 (06) : 695 - 704
  • [4] CURRENT CONCEPTS - CHRONIC URTICARIA
    GREAVES, MW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (26) : 1767 - 1772
  • [5] AUTOANTIBODIES AGAINST THE HIGH-AFFINITY IGE RECEPTOR AS A CAUSE OF HISTAMINE-RELEASE IN CHRONIC URTICARIA
    HIDE, M
    FRANCIS, DM
    GRATTAN, CEH
    HAKIMI, J
    KOCHAN, JP
    GREAVES, MW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) : 1599 - 1604
  • [6] Modulation of autoimmune responses by intravenous immunoglobulin (IVIg)
    Kaveri, S
    Prasad, N
    Vassilev, T
    Hurez, V
    Pashov, A
    LacroixDesmazes, S
    Kazatchkine, M
    [J]. MULTIPLE SCLEROSIS, 1997, 3 (02): : 121 - 128
  • [7] LacroixDesmazes S, 1996, CLIN EXP RHEUMATOL, V14, pS9
  • [8] O'Donnell BF, 1998, BRIT J DERMATOL, V138, P101
  • [9] STOHL W, 1986, J IMMUNOL, V136, P4407
  • [10] Vassilev T, 1997, Ther Apher, V1, P38, DOI 10.1111/j.1744-9987.1997.tb00011.x
1